We are live on
!
Find out more
ADIM
Alpha DNA Investment Management Portfolio holdings
AUM
$8.98M
1-Year Est. Return
26.05%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$120M
AUM Growth
+$3.1M
(+2.6%)
Cap. Flow
+$30.4M
Cap. Flow
% of AUM
25.24%
Top 10 Holdings %
Top 10 Hldgs %
19.44%
Holding
209
New
93
Increased
10
Reduced
42
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$3.43M |
| 2 |
JPMorgan Chase
JPM
|
+$2.49M |
| 3 |
Visa
V
|
+$2.46M |
| 4 |
Pfizer
PFE
|
+$2.46M |
| 5 |
Analog Devices
ADI
|
+$1.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revvity
RVTY
|
+$1.28M |
| 2 |
LyondellBasell Industries
LYB
|
+$1.25M |
| 3 |
Fastenal
FAST
|
+$1.23M |
| 4 |
Qualcomm
QCOM
|
+$1.21M |
| 5 |
Occidental Petroleum
OXY
|
+$1.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.77% |
| 2 | Financials | 18.53% |
| 3 | Energy | 14.69% |
| 4 | Industrials | 14.26% |
| 5 | Healthcare | 13.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Axcelis
ACLS
$4.18B
| $516K | 0.43% |
+8,528
| New | +$551K |
|
|
CCRN
127
DELISTED
Cross Country Healthcare
CCRN
| $516K | 0.43% |
18,209
-31,189
| -63% | -$802K |
|
128
Advanced Energy
AEIS
$13.1B
| $512K | 0.43% |
+6,616
| New | +$568K |
|
129
nVent Electric
NVT
$27.1B
| $510K | 0.42% |
+16,142
| New | +$539K |
|
130
Bank OZK
OZK
$5.66B
| $510K | 0.42% |
+12,914
| New | +$520K |
|
131
Champion Homes
SKY
$5.11B
| $510K | 0.42% |
9,648
-9,708
| -50% | -$566K |
|
132
Diamondrock Hospitality Co
DRH
$2.46B
| $503K | 0.42% |
+67,042
| New | +$591K |
|
133
FNB Corp
FNB
$6.8B
| $503K | 0.42% |
+43,378
| New | +$514K |
|
134
Oxford Industries
OXM
$542M
| $501K | 0.42% |
5,585
-4,415
| -44% | -$427K |
|
|
AMWD
135
DELISTED
American Woodmark
AMWD
| $496K | 0.41% |
+11,321
| New | +$552K |
|
136
Provident Financial Services
PFS
$3.23B
| $491K | 0.41% |
25,209
-22,842
| -48% | -$533K |
|
|
GMS
137
DELISTED
GMS Inc
GMS
| $490K | 0.41% |
+12,263
| New | +$587K |
|
138
Impinj
PI
$5.32B
| $490K | 0.41% |
+6,134
| New | +$511K |
|
139
Marten Transport
MRTN
$1.18B
| $480K | 0.4% |
25,080
-34,835
| -58% | -$697K |
|
140
Lakeland Financial Corp
LKFN
$1.54B
| $474K | 0.39% |
+6,515
| New | +$486K |
|
141
TTM Technologies
TTMI
$13.8B
| $474K | 0.39% |
+35,985
| New | +$519K |
|
142
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$54.9B
| $418K | 0.35% |
8,346
-17,556
| -68% | -$988K |
|
143
iShares Core S&P 500 ETF
IVV
$902B
| $360K | 0.3% |
1,005
-695
| -41% | -$278K |
|
144
iShares ESG Aware MSCI USA ETF
ESGU
$18.3B
| $276K | 0.23% |
3,483
-1,384
| -28% | -$123K |
|
145
Celanese
CE
$4.92B
| $224K | 0.19% |
2,488
-8,165
| -77% | -$897K |
|
146
American Airlines Group
AAL
$10.1B
| – | – |
-71,027
| Closed | -$900K |
|
147
Airbnb
ABNB
$111B
| – | – |
-11,887
| Closed | -$1.06M |
|
148
Albertsons Companies
ACI
$5.95B
| – | – |
-39,016
| Closed | -$1.04M |
|
149
Allegiant Air
ALGT
$2.42B
| – | – |
-8,034
| Closed | -$908K |
|
150
Advanced Micro Devices
AMD
$774B
| – | – |
-14,816
| Closed | -$1.13M |
|
Similar funds
CAWM
AI
PC
CP
AVM
CSD
NP
BPWM
Alpha DNA Investment Management's Q3 2022 Portfolio in Review
As of Q3 2022, Alpha DNA Investment Management held 209 positions worth $120M, up 2.6% from $117M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Alpha DNA Investment Management deployed $30.4M of net new capital in Q3 2022, opening 93 new positions and adding to 10 existing holdings. Its largest new stake was ExxonMobil: 37,550 shares worth $3.28M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Energy.
On the sell side, the largest reduction was State Street SPDR Portfolio S&P 500 Growth ETF, an estimated $988K trimmed.
- Alpha DNA Investment Management's largest Q3 2022 buy was ExxonMobil: 37,550 shares worth $3.28M.
- Alpha DNA Investment Management added most to Analog Devices in Q3 2022, an estimated $1.93M increase.
- Alpha DNA Investment Management's biggest Q3 2022 reduction was State Street SPDR Portfolio S&P 500 Growth ETF, cutting an estimated $988K.
- Alpha DNA Investment Management fully exited Revvity in Q3 2022, selling an estimated $1.28M.
- Alpha DNA Investment Management's ten largest holdings make up 19% of its $120M portfolio in Q3 2022.
- Alpha DNA Investment Management opened 93 new positions and closed 64 in Q3 2022.
- Alpha DNA Investment Management's portfolio value rose 2.6% quarter-over-quarter to $120M.
Based on Alpha DNA Investment Management's 13F filing for Q3 2022, filed 15 Nov 2022.